LANXESS: EBITDA pre exceptionals for the fourth quarter significantly above market expectation

Ad hoc according to Art. 17 paragraph 1 MMVO

Specialty chemicals company LANXESS expects to have achieved about EUR 159 million EBITDA pre exceptionals for the fourth quarter 2024. This significantly exceeds market expectation of currently EUR 130 million (VARA consensus) by 22 percent.

EBITDA pre exceptionals for the full year 2024 is therefore expected to amount to around EUR 614 million, approximately 20 percent above prior year’s level and at the upper end of the previously guided range of 10-20% growth.

The fourth quarter was positively influenced by a stronger than expected December, in particular due to customers’ pre-buying. This pull-forward effect occurred mainly in the U.S. for products of the segments Specialty Additives and Consumer Protection.

The underlying macroeconomic environment going into 2025 has however not improved.

The fiscal year 2024 will end with around EUR 2.4 billion net financial debt compared to EUR 2.5 billion at the end of 2023.

LANXESS will release its final results for the fourth quarter 2024 and the fiscal year 2024 on March 20, 2025. All figures provided in this release are preliminary and unaudited.

Cologne, 20 January 2025 

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

INVESTOR NEWS

LANXESS expects business to pick up in the second half of 2026 at the earliest

March 19, 2026
INVESTOR NEWS

LANXESS: Moody’s rating change with limited impact on financing costs

March 09, 2026
INVESTOR NEWS

LANXESS: Update on ENVALIOR Stake

March 05, 2026
INVESTOR NEWS

Challenging market environment shapes third quarter of 2025

November 06, 2025
INVESTOR NEWS

LANXESS exercises right to offer for the sale of its shares in Envalior in 2026

September 23, 2025